106 related articles for article (PubMed ID: 30810967)
1. Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population.
Kotani H; Ito H; Kuwahara K; Kuzushima K; Iwata H; Tsunoda N; Nagino M; Matsuo K
Breast Cancer; 2019 Sep; 26(5):562-572. PubMed ID: 30810967
[TBL] [Abstract][Full Text] [Related]
2. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
[TBL] [Abstract][Full Text] [Related]
3. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
4. MCM3AP is transcribed from a promoter within an intron of the overlapping gene for GANP.
Wickramasinghe VO; McMurtrie PI; Marr J; Amagase Y; Main S; Mills AD; Laskey RA; Takei Y
J Mol Biol; 2011 Feb; 406(3):355-61. PubMed ID: 21195085
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer.
Zhang W; Zhang ZZ; Tang LY; Lin Y; Su FX; Xie XM; Su XF; Ren ZF
Tumour Biol; 2016 Jun; 37(6):8337-47. PubMed ID: 26729199
[TBL] [Abstract][Full Text] [Related]
6. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
7. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
8. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in homologous recombination repair genes and the risk and survival of breast cancer.
Liao YH; Ren JT; Zhang W; Zhang ZZ; Lin Y; Su FX; Jia WH; Tang LY; Ren ZF
J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28940489
[TBL] [Abstract][Full Text] [Related]
10. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
[TBL] [Abstract][Full Text] [Related]
12. Germinal Center B-Cell-Associated Nuclear Protein (GANP) Involved in RNA Metabolism for B Cell Maturation.
Sakaguchi N; Maeda K
Adv Immunol; 2016; 131():135-86. PubMed ID: 27235683
[TBL] [Abstract][Full Text] [Related]
13. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
14. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
15. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Harvey VJ; Neven P; Treilleux I; Rasmussen BB; Maibach R; Price KN; Coates AS; Goldhirsch A; Pagani O; Viale G; Rae JM; Regan MM
Breast Cancer Res Treat; 2015 Jun; 151(2):373-84. PubMed ID: 25935582
[TBL] [Abstract][Full Text] [Related]
16. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
[TBL] [Abstract][Full Text] [Related]
17. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
19. Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism.
He Y; Liu H; Chen Q; Shao Y; Luo S
Mol Genet Genomic Med; 2019 Sep; 7(9):e871. PubMed ID: 31317673
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
